FDA DEVICE FACTS
InferCare RECIST
Beijing Infervision Healthcare Medical Technology Co., Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
InferCare RECIST is a post-processing software application used to display, process , analyze , quantify and manipulate multi-time-point CT images. It is intended to be used by trained medical professionals in evaluating and managing tumors in various organs, tissues , and other anatomical structures based on RECIST criteria. InferCare RECIST offers functionalities for lesion measurement , registration , tracking , and RECIST report . It provides tools for interactive segmentation , and 3D reconstruction visualization . The software utilizes artificial intelligence algorithms for automated lesion segmentation and registration , and the results require confirmation by a medical professional. The software's artificial intelligence algorithms are intended for patients aged 21 years and older.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。